Opinion

Video

Clinical Utility of the Modified Friedreich Ataxia Rating Scale

Key Takeaways

  • mFARS is designed to assess Friedreich Ataxia progression in clinical trials, focusing on motor function and disease severity.
  • Its complexity and time requirements may limit routine use in everyday clinical practice.
SHOW MORE

Sub Subramony, M.D., discusses how the modified Friedreich Ataxia Rating Scale (mFARS) is valuable for monitoring disease progression in clinical trials and its applicability in everyday clinical practice for assessing patient status.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Video content above is prompted by the following:

      The modified Friedreich Ataxia Rating Scale (mFARS) has been developed to monitor FA disease progression in clinical trials. Is mFARS useful in your everyday clinical practice?

      Related Content
      AJMC Managed Markets Network Logo
      CH LogoCenter for Biosimilars Logo